Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ODC1 | P11926 | 1/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29962101 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL3852726 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL30651 | 0.84 | ALDH1A1 (0.42) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL30787966 | 0.78 | ARG2 (0.41) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL11087825 | 0.77 | ODC1 (0.48) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL5904292 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL1416683 | 0.77 | ALDH1A1 (0.37) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL3854199 | 0.77 | ALDH1A1 (0.37) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| SCHEMBL1416684 | 0.77 | ALDH1A1 (0.37) | ALDH1A1TSHRHTTMEN1CYP1A2 | |
| Hydrochloric Acid SCHEMBL2302947 | 0.77 | ARG2 (0.40) | ALDH1A1TSHRHTTMEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1686114-B1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL CO (JP) | 2009-10-07 | — | — | EP | disclosed |
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-7470525-B2 | Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2008-12-30 | — | — | US | disclosed |
| EP-1634957-B1 | 2-ALKYLCYSTEINAMIDE OR SALT THEREOF, PROCESS FOR PRODUCING THESE, AND USE OF THESE | MITSUBISHI GAS CHEMICAL CO (JP) | 2008-10-08 | — | — | EP | disclosed |
| US-7208631-B2 | 2-alkylcysteinamide or salt thereof, process for producing these, and use of these | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-04-24 | — | — | US | disclosed |
| US-20070037260-A1 | allowing cells of microorganism or treated products thereof having an activity of stereoselective hydrolysis of the amide bond of a 2-alkyl-L-cysteinamide or a salt thereof to act on a 2-alkylcysteinamide consisting of a mixture of D- and L-isomers or a salt thereof | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-20060287398-A1 | 2-alkylcysteinamide or salt thereof, process for producing these, and use of these | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-12-21 | — | — | US | disclosed |
| EP-1686114-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTEINE, DERIVATIVE THEREOF, AND PROCESSES FOR PRODUCTION | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-08-02 | — | — | EP | disclosed |
| EP-1634957-A1 | 2-ALKYLCYSTEINAMIDE OR SALT THEREOF, PROCESS FOR PRODUCING THESE, AND USE OF THESE | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2006-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060287398-A1 | 2-alkylcysteinamide or salt thereof, process for producing these, and use of these | CBS, AHCY, CTH | ALDH1A1 440/4885TSHR 2291/4885HTT 1671/4885 |
| US-20090030210-A1 | Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production | AADAT, CBS, CTH | ALDH1A1 444/4885TSHR 4348/4885HTT 1136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.